Clinical study regarding the atherogenic properties of the oxidatively modified low-density lipoproteins

Archives of the Balkan Medical Union

Volumn 39, Issue 2, 2004, Pages 78-82

  Margina D ^a   Gradinaru D ^a   Mitrea, Niculina ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Atherosclerosis; Dislipidemia; Low density lipoproteins; Oxidized LDL; Thiobarbituric acid reactive substances

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE;

EID: 12444317624     PISSN: 15849244     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. De Rijke Y.B., Vogelezang C.J.M., Van Berker T.J.C., Princen H.M.G., Verwey H.E, Van Der Laarse A., Bruschke A.V.G. - Susceptibility of low-density lipoproteins to oxidation in coronary bypass patients, Lancet, 1992, 340, 859-859.
2. Holvoet P., Perez G., Zhao Z., Brouwers E., Bernar H., Collen D.- Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease, J. Clin. Invest., 1995, 95, 2611-2619.
3. Esterbauer H., Striegl G., Puhl H., Rotheneder M.- Continuous monitoring of in vitro oxidation of human low-density lipoproteins, Free Rad. Res. Commun., 1989, 6, 67-75.
4. El-Saadani M., Esterbauer H., El-Sayed M., Goher M., Nassar A.Y., Jurgens G. - A spectrophotometric assay for lipid peroxides in serum lipoproteins using commercially available reagent, J. Lipid Res., 1989, 30, 627-630.
5. Giessauf A., Steiner E., Esterbauer H. - Early destruction of tryptophan residues of apolipoprotein B is a vitamin E-dependent process during copper-mediated oxidation of LDL, Biochim. Biophys. Acta, 1995, 1256, 221-232.
6. Jurgens G., Hoff H.F., Chisolm G.M., Esterbauer H.- Modification of human serum low-density lipoprotein by oxidation: characterisation and patophysiological implications, Chem. Phys. Lipids, 1987, 45, 315-336.
7. Libby P. - Inflamation in atherosclerosis, Nature, 2002, 420, 868-874.
8. Jacotot B., Castaigne A. - Athérosclérose coronaire-physiopathologie, dépistage, prévention, PIL, 1996, 43-83.
9. Pittman R., Steinberg D.- Sites and machanisms of uptake and degradation of high density and low density lipoproteins, J. Lipid Res., 1984, 25, 1577-1585.
10. Parthasarathy S., Khoo J., Miller E., Barnett J., Witztum J., Steinberg D. - Low density lipoprotein rich in oleic acid is protected against oxidative modification: Implications for dietary prevention of atherosclerosis, Proc. Natl. Acad. Sci. USA, 1990, 87, 3894-3898.
11. Ross R. - Atherosclerosis-an Inflammatory Disease, New Engl. J. Med., 1999, 340, 115-126.
12. Shamir R., Johnson W., Morlock-Fitzpatrick K, Zolfaghari R., Ling Li, Mas E. - Pancreatic carboxyl ester lipase: a circulating enzyme that modifies normal and oxidized lipoproteins in vitro, J. Clin. Invest., 1996, 97, 1696-1704.